Strategic Advocates’s Doximity DOCS Stock Holding History

Strategic Advocates’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$146	–	641
2025 Q3	$146	Buy	+2	New	+$130	﹤0.01%	570

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Strategic Advocates's DOCS Position: Q4 2025 in Review

Strategic Advocates sold out of Doximity (DOCS) in Q4 2025, closing a stake of 2 shares — an estimated $146 sold.

Strategic Advocates first reported a position in DOCS in Q3 2025 and held it in 1 quarter. The position peaked at $146 in Q3 2025. 470 funds tracked by Wall St. Rank hold DOCS as of Q4 2025.

Strategic Advocates reported no remaining Doximity position as of Q4 2025 after selling out during the quarter.
Strategic Advocates sold 2 Doximity shares in Q4 2025, an estimated $146.
Strategic Advocates first reported a position in Doximity in Q3 2025 and held it in 1 quarter.
Strategic Advocates's Doximity position peaked at $146 in Q3 2025.
470 funds tracked by Wall St. Rank held Doximity as of Q4 2025.

Based on Strategic Advocates's 13F filing for Q4 2025, filed 11 Feb 2026.